Based on UPLC-LTQ-Orbitrap-MS and network pharmacology methods to explore the potential mechanism of Liuwei Dihuang pills in the treatment of AD*

WANG Di

Chinese Journal of Pharmaceutical Analysis ›› 2022, Vol. 42 ›› Issue (4) : 580-589.

PDF(3522 KB)
PDF(3522 KB)
Chinese Journal of Pharmaceutical Analysis ›› 2022, Vol. 42 ›› Issue (4) : 580-589. DOI: 10.16155/j.0254-1793.2022.04.04
Ingredient Analysis

Based on UPLC-LTQ-Orbitrap-MS and network pharmacology methods to explore the potential mechanism of Liuwei Dihuang pills in the treatment of AD*

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 42(4): 580-589 https://doi.org/10.16155/j.0254-1793.2022.04.04

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(3522 KB)

Accesses

Citation

Detail

Sections
Recommended

/